New implantable glucose monitor put to the test
Disease control
Recruiting now
This study is testing a new, long-term glucose monitoring system called Eversense Gemini for people with diabetes. It aims to see how accurately it measures blood sugar compared to standard fingerstick checks and an older version of the monitor. The study will also check the safe…
Phase: NA • Sponsor: Senseonics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC